Video Author: Mary Ellen Schneider Publish date: December 19, 2018
SAN DIEGO – Dr. Brian Hill and Dr. Anthony Mato break down the take-home points from the key studies on chronic lymphocytic leukemia presented at A...
Video Author: Mary Ellen Schneider Publish date: December 11, 2018
SAN DIEGO – Dr. Amber Yates said being active on Twitter has helped her streamline the journals she reads.
Video Author: Mary Ellen Schneider Publish date: December 5, 2018
SAN DIEGO – Positive phase 1 results keep LCAR-B38M in the CAR T race in multiple myeloma.
Video Author: Mary Ellen Schneider Publish date: December 4, 2018
SAN DIEGO – Dr. Keith W. Pratz reviewed results from a phase 1 study of gilteritinib and next steps in newly diagnosed patients.
Video Author: Mary Ellen Schneider Publish date: December 2, 2018
SAN DIEGO – The umbrella trial, sponsored by the Leukemia & Lymphoma Society, harnesses technology to speed genomic results that could personal...
News Author: Mary Ellen Schneider Publish date: December 2, 2018
SAN DIEGO – For sickle cell patients, opioid-related mortality is essentially a “never” event.
Video Author: Mary Ellen Schneider Publish date: December 1, 2018
SAN DIEGO – Dr. Ify Osunkwo described the latest approaches, from gene therapy to haploidentical stem cell transplant, as well as patient access ch...
News Author: Mary Ellen Schneider Publish date: November 29, 2018
The editorial advisory board members of Hematology News explain what they’re watching at ASH 2018.
News Author: Mary Ellen Schneider Publish date: November 19, 2018
Bortezomib may help overcome treatment resistance in patients with Waldenström’s macroglobulinemia (WM) and CXCR4 mutations, according to a new study....
News Author: Mary Ellen Schneider Publish date: November 15, 2018
The qualitative study found that patients reported feeling like they were on an “emotional roller coaster” during their treatment.
News Author: Mary Ellen Schneider Publish date: November 15, 2018
The study tested how a bortezomib treatment combination would perform in patients with CXCR4 mutations.
News Author: Mary Ellen Schneider Publish date: October 19, 2018
Preliminary findings have researchers questioning why cardiac testing is routine before administering chemotherapy containing doxorubicin.
News Author: Mary Ellen Schneider Publish date: October 18, 2018
A single-institution study examines the impact of early dose reduction of ibrutinib in non-Hodgkin lymphoma and CLL.
News Author: Mary Ellen Schneider Publish date: October 17, 2018
This sets the stage for a future approval of the first chemo-free anti-CD20 combination for frontline treatment o...
News Author: Mary Ellen Schneider Publish date: October 11, 2018
The oral, selective inhibitor of spleen tyrosine kinase had a high rate of adverse events and treatment interruption in the phase 2 study.
